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Abstract
Brain microvascular endothelial cells (BEC) constitute the blood-brain barrier (BBB) which forms a dynamic interface
between the blood and the central nervous system (CNS). This highly specialized interface restricts paracellular diffusion of
fluids and solutes including chemicals, toxins and drugs from entering the brain. In this study we compared the
transcriptome profiles of the human immortalized brain endothelial cell line hCMEC/D3 and human primary BEC. We
identified transcriptional differences in immune response genes which are directly related to the immortalization procedure
of the hCMEC/D3 cells. Interestingly, astrocytic co-culturing reduced cell adhesion and migration molecules in both BECs,
which possibly could be related to regulation of immune surveillance of the CNS controlled by astrocytic cells within the
neurovascular unit. By matching the transcriptome data from these two cell lines with published transcriptional data from
freshly isolated mouse BECs, we discovered striking differences that could explain some of the limitations of using cultured
BECs to study BBB properties. Key protein classes such as tight junction proteins, transporters and cell surface receptors
show differing expression profiles. For example, the claudin-5, occludin and JAM2 expression is dramatically reduced in the
two human BEC lines, which likely explains their low transcellular electric resistance and paracellular leakiness. In addition,
the human BEC lines express low levels of unique brain endothelial transporters such as Glut1 and Pgp. Cell surface
receptors such as LRP1, RAGE and the insulin receptor that are involved in receptor-mediated transport are also expressed
at very low levels. Taken together, these data illustrate that BECs lose their unique protein expression pattern outside of
their native environment and display a more generic endothelial cell phenotype. A collection of key genes that seems to be
highly regulated by the local surroundings of BEC within the neurovascular unit are presented and discussed.
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Introduction
The specific microenvironment of the central nervous system
(CNS) is vital for proper neuronal function. A key feature which
provides and maintains the extracellular medium compatible with
normal neuronal activity is the blood brain barrier (BBB).
Consequently, the failure of BBB structural integrity and function
plays a pivotal role in the pathogenesis of many diseases of the
CNS [1,2]. The anatomical constituents of the BBB are the
specialized brain endothelial cells (BECs) that together with
pericytes, astrocytes, neurons, and possibly other glial cells,
comprise the neurovascular unit (NVU) [3,4,5,6]. Although all
these cell types contribute to the functioning of the brain
microvasculature, only the BECs are thought to control perme-
ability directly or indirectly via stimuli from the other cells in the
NVU [7,8].
While the BBB performs an important function in keeping out
unwanted or harmful molecules from the brain, it poses a
challenge for delivering valuable therapeutics such as anticancer,
antibiotic, neuroprotective or antipsychotic drugs into the brain.
Consequently, finding beneficial molecules that also cross the BBB
is an increasing problem within the pharmaceutical industry,
especially if these molecules are large biotherapeutics such as
proteins and antibodies. There is a growing need for reliable
bench models that predict important in vivo properties. These
models would facilitate our understanding of key biological
functions of the BBB and allow study of specific transport systems
potentially suitable for delivering drugs to the brain. Pharmaceu-
tical research in particular is dependent on well characterized and
easy to handle in vitro models. Therefore, BEC culture models have
been developed for the study of the BBB with an attempt to mimic
important in vivo properties. Over the last few years, the isolation
and culture of BEC have advanced significantly, resulting in a
variety of BBB models.
Endothelial cells (ECs) from various brain regions and species
have been used. The cells have been isolated by different
techniques and variation in subsequent culturing procedure of
the BECs has also been evaluated [9,10]. One limitation of cell
cultures is their potential dedifferentiation behavior where the cells
lose properties they originally inherently possessed due to the lack
of the natural in vivo environment [11,12], such as gene expression
patterns and certain functionalities. Therefore, attempts have also
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them with astrocytes or pericytes [13] or by using sheer stress [14].
This has in many cases improved some of the properties of the
BECs, such as increased restriction in paracellular leakiness and
elevated transendothelial electric resistance (TEER). Unfortunate-
ly only a limited number of proteins and a few properties have
been studied in cultured BECs, meaning that our basic under-
standing of what regulates BEC properties is very restricted.
Furthermore our knowledge about the global expression pattern in
cultured BECs is still very incomplete.
The aim of this study was to increase our understanding of gene
expression patterns which are required for a well-functioning in
vitro BBB model. This was performed by quantifying the global
gene expression profile in the hCMEC/D3 cell line and in primary
human BEC (hpBEC). The hCMEC/D3 has been used and
characterized extensively to study BBB properties in vitro, so this
cell line functioned as a good reference for a cellular BEC model
[15]. The hCMEC/D3 cell line was generated by immortalization
of primary human brain capillary endothelial cells via a lentiviral
vector system. The hpBEC was included as a model system for
primary brain endothelial cells that could potentially demonstrate
important differences compared to a stable cell line. The
hCMEC/D3 cell line has been shown to express typical
endothelial cell markers, such as CD31, VE-cadherin and von
Willebrand factor, to show a stable karyotype, to preserve contact
inhibition for monolayers in culture and to form capillary tubes in
matrix [15]. However, the cells show deficiency in typical and
important brain endothelial properties such as low TEER value
and relative high permeability towards small tracer molecules
indicating paracellular leakiness and suboptimal formation of tight
junctions (TJs). In our hands, similarly poor functional properties
were observed for the hpBEC regardless of their primary source
also indicating issues with appropriate TJ formation.
In order to understand these suboptimal functional properties a
global transciptome analysis was performed on these two BEC
lines. The transcription profile was compared with a recently
published analysis of freshly isolated mouse brain BECs [16]. A
recent cross-species analysis showed that gene expression is
significantly preserved between the two species [17], supporting
the comparisons of human and mouse transcriptome data. The
comparison clearly showed that critical genes reported to be
responsible for structural and functional properties of the TJ are
expressed at very low levels in both cell lines. Two key genes
specifically found in BECs, claudin-5 and occludin, are expressed
at very low levels, not only in comparison to the mouse data but
also in comparison to other TJ genes. We also found major
differences in the SLC and ABC transporter families. In particular,
family members that are known to be characteristic of BECs, such
as Glut1, Pgp, MRP4 and BCRP, are expressed at very low levels
based on a similar comparison. In addition, the analysis also
indicates major differences in the expression pattern of a collection
of important cell surface receptors, which also have direct
implications for the study of transport mechanisms. Genes altered
due to the immortalization procedure are also identified and are
linked to the immune and interferon pathways. This analysis
clarifies many of the atypical BBB properties of the BEC lines and
can be explained by this gene expression analysis which has
generated essential information to further improve in vitro BBB
models. One interesting observation is the specific down-regula-
tion of adhesion molecules on the BECs in the presence of
astrocytes. This might be linked to a novel function of astrocytes in
regulating cell adhesion and, indirectly, immune surveillance of
the CNS.
Taken together, our data strongly indicate that brain ECs lose
their unique protein expression pattern outside their native in vivo
environment resulting in a more generic EC phenotype. Our
findings indicate that specific transcription of genes in brain ECs
are at least in part dictated by other cells within the NVU.
Results
Different endothelial marker expression and growth
behavior of the hCMEC/D3 and hpBEC cells
Flow cytometry analysis (FACS) for CD31 (Figure 1a), CD34
(Figure 1a), CD105 (Figure 1b) and CD54 (Figure 1c)o f
hpBECs and hCMEC/D3 cells confirmed their endothelial
identity [15,18] and purity, but also revealed some differences
between these BEC lines. The surface expression of CD31 on both
cell lines is similar, whereas the hpBECs are negative for CD34
(Figure 1a). In comparison to the hCMEC/D3, the hpBECs
express more CD105 (Figure 1b) but lower levels of CD54
(Figure 1c). This is in agreement with the transcriptional data
where the hCMEC/D3 cells had log2 values of 11.78 for CD31,
9.21 for CD34, 9.97 for CD105 and 8.13 for CD54. The hpBECs
cells on the other hand had log2 values of 10.11 for CD31, 6.42 for
CD34, 10.83 for CD105 and 8.87 for CD54 (Table S1). In
addition, phosphorylation of the endothelial cell-specific receptor
tyrosine kinase TIE2 [16,19] following stimulation with 1 mM
pervanadate was also confirmed positive on both cells (97.8% of
the hpBECs & 98.4% of the hCMEC/D3) (data not shown).
The dynamic monitoring of the hCMEC/D3 growth and
viability, using the xCelligence RT-CA system [20,21], revealed
some large differences compared to the hpBECs (Figure 1d). The
interaction of adherent mammalian cells with the microelectrodes
of the xCelligence RT-CA system leads to an impedance change
that is proportional to the cell number and morphology as well as
the quality of cell attachment [20,21]. Our data show that the
hpBECs are unable to form a stable confluent monolayer over an
extended period and show sensitivity to media components of the
Growth Medium (EGM-2 supplemented EBM-2 Medium, see
Material and Methods) (Figure 1d). After a log growth phase, the
hCMEC/D3 cells reach a plateau that persists for several days
without major fluctuations. The use of Resting Medium lacking
the endothelial growth factors gave a slightly higher cell index (CI)
for the hCMEC/D3 during their plateau phase which was not
advantageous for the hpBECs (Figure 1d). The morphological
and proliferative characteristics are confirmed by phase contrast
microscopy (Figure S1). In addition to the difference in cell size,
we observed that based on cell number calculations the hCMEC/
D3 are 5-fold significantly tighter packed then the hpBECs 3 days
post seeding(p,0.001) . Freshly plated hCMEC/D3 typically grew
to confluence within 2–3 days. Light microscopy of the monolayer
at 3 days post seeding revealed a characteristic elongated spindle
shaped morphology of the cells (Figure S1) typical for primary or
low passage microvascular endothelial cultures. However, we
observed that culturing the hCMEC/D3 cells for more than 7
days after confluence (or 10 days after cell seeding) resulted in cell
overgrowth on the transwell filters (data not shown).
Gene expression differences between immortalized and
primary BECs
We assessed the overall gene expression profile for the
immortalized hCMEC/D3 and primary hpBEC cell lines using
published standard growing conditions (see Material & Meth-
ods). A total of 21460 probe sets out of 38172 high quality probe
sets (56%) surveyed by microarray met the criteria to be
considered expressed (i.e. hybridization signal above cutoff $5
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PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e38149Figure 1. Immortalization influences BEC phenotype, growth behavior and expression of cell division related genes. (A–C) Flow
cytometry analysis of confluent hCMEC/D3 (red population, red histograms) and hpBECs (blue population, blue histograms) seeded on collagen I
coated inserts. Staining was done with indicated antibodies or relevant isotype controls (grey population, tinted histograms). The average population
sizes and standard deviations of three similar experiments are shown in A, whereas one representative experiment of three is shown in B&C
(MFI=mean fluorescence intensity). (D) Real time monitoring of adherent BECs cultured in Resting (RM) or Growth Medium (GM) by the xCeLLIgence
System. The curves show the time-, attachment- and density-dependent cell growth and viability of the individual BEC lines respectively culturing
conditions. (E) Comparison of gene expression between hCMEC/D3 cells and hpBECs. The data is represented as a dot plot on a log2 scale, where
each point represents a probe set on the gene chip. Red and blue dots indicate probe sets, which have higher expression in hCMEC/D3 (red) or
higher expression in hpBECs (blue). The mean expression values are averaged expression values for both cell lines. (F) The enrichment map displays
the differently expressed gene sets between the two BEC lines. Red node color represents higher expression in hCMEC/D3 cells, whereas blue
represents higher expression in hpBECs. Node size is proportional to the number of genes in the gene set and edge thickness represents the degree
of overlap between two gene sets. Labels for the clusters of functionally related gene sets were manually assigned: 1) Mitosis, 2) DNA Repair, 3)
Anaphase Promoting Complex, 4) Immune and Virus Response, 5) RNA Processing, 6) Cell-Cell Adhesion, 7) Differentiation/Maturation/Development,
8) Metabolic Processes, 9) Miscellaneous.
doi:10.1371/journal.pone.0038149.g001
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determination (R
2) for mRNA levels between the cell lines was
0.912 (p,1.68 ? 10
26), meaning that 91% of the variance in gene
expression of one cell line is accounted for by levels of gene
expression in the other cell line. Pairwise comparison between the
immortalized hCMEC/D3 versus primary hpBECs revealed a
large proportion of probe sets that were significantly differently
expressed ($10-fold=2% of all high quality probe sets). This limit
($10-fold) led to the identification of 148 and 272 genes as higher
or lower expressed, respectively, in the hCMEC/D3 cells (Table
S1). This is graphically represented by a dot plot where each dot
represents a probe set on the Affymetrix GeneChip and its position
relative to the log2 (Figure 1e). The axes represent expression
levels in the different cell types. Gene set enrichment analysis was
performed using gene ontology (GO) biological process gene sets.
Only gene sets passing conservative significance thresholds
(p#0.05) are displayed in the enrichment map (Figure 1f)
resulting in 154 GO categories which differed between the cell
types (Table S2). The enrichment map visualizes functionally
coherent gene sets [22], in which gene sets are organized into a
similarity network, where nodes represents gene sets and weighted
links between the nodes represent the overlap of member genes
[23]. Most of the higher-expressed genes in hCMEC/D3 were
involved in DNA repair, RNA processing, mitosis and immune/
virus response (Figure 1f, Table S1 & S2). This is not
completely unexpected since the hCMEC/D3 cells have been
immortalized by co-expression of human telomerase reverse
transcriptase (hTERT) and the Simian virus (SV40) large T
antigen (TAg) [15]. SV40 TAg is a powerful viral oncoprotein
capable of transforming a variety of cell types, leading to expanded
proliferation and survival potentials [24,25,26]. The majority of
the higher-expressed genes in the hpBECs can be related to
catabolic/metabolic processes, vesicle transport, endothelial cell
migration and differentiation/maturation (Figure 1f, Table S1
&S 2 ).
Interferon related genes up regulated in hCMEC/D3 cells
By comparing the most differently expressed genes in the
hCMEC/D3 with those in the hpBECs we found that many of
them are linked to viral infection and can be assigned to the
interferon (IFN) signaling pathway, as defined by the Reactome
database [27] (Table S1). Among those 132 genes which are 10-
fold or more expressed in the hCMEC/D3 cells compared to the
hpBECs, 13% belong to the IFN signaling pathway. By comparing
the expression levels of the 64 INF signaling genes present on the
arrays between the cell types, we can see a significant increase of
expression (p,0.0001) in the hCMEC/D3 (Figure 2a & Table
S3). A comparable picture was seen for INFa/b and INFc
pathways (Figure 2a). While the transcription of the IFN-
stimulated genes (ISGs) is enhanced in the hCMEC/D3 cells, the
transcription of the IFNs, IFN-receptors and IFN associated
signaling molecules are comparably high in both cell types (Table
S3). Exposure of human cells to viral proteins induces the
production IFNs. Therefore the IFN system is the first line of viral
defense and a powerful antitumor response in vertebrates [28,29].
Recent evidence suggests that many of the ISGs are indeed
induced by SV40 TAg [30] and affect many aspects of cellular
physiology [31]. INFa/b exert their antiviral and antitumor effects
through mechanisms that include the induction of MHC class I
molecules (MHC I) expression on the cell surface of infected or
oncogenic transformed cells [32,33,34,35,36]. IFNc, on the other
hand, increases both MHC I expression and leads to a de novo
expression of MHC class II (MHC II) molecules [37]. In fact we
observed a significantly enhanced expression of all MHC I
(Figure 2b & Table S1) and certain MHC II haplotypes (HLAs)
(Table S1) in the hCMEC/D3 cells versus the hpBECs on
transcriptional level. This observation could be validated at
protein level by FACS staining of MHC I HLA-A,B,C
(Figure 2c & 2d) and MHC II HLA-DR,DP,DQ (Figure 2e)
between the cell types, in which the hCMEC/D3 cells showed a
10-fold higher basal surface expression of HLA-A,B,C (Figure 2c
&2 d ) and a 4-fold higher basal surface expression of HLA-
DR,DP,DQ (Figure 2e). The HLA-A,B,C basal surface expres-
sion on HUVECs showed similar MFI (MFI=11269) to the
pBECs. The effects of IFNa and IFNc stimulation upon BECs
surface expression of HLA-A,B,C and HLA-DR,DP,DQ were also
examined by FACS quantification (Figure 2d & 2e). As can be
seen in Figure 2d IFNa stimulation caused a 6-fold increase in
hpBECs and a doubling of HLA-A,B,C surface expression in
hCMEC/D3. Similarly, IFNc stimulation caused a 5-fold increase
in hpBECs and a non-significant doubling of HLA-DR,DP,DQ
surface expression in hCMEC/D3 cells (Figure 2e). The data
suggest that the hCMEC/D3 is already in a stimulated state with
high expression of MHC molecules on the cell surface which is
likely to be caused by the immortalization procedure using SV40
TAg.
Astrocytic co-culturing modulates the immune state of
the BECs
Contact co-culture with astrocytes has been reported to restore
some of the dedifferentiated BBB phenotype of isolated BECs
[38,39,40] by having a particular impact on the expression and
maintenance of the tight junction (TJ) proteins
[38,40,41,42,43,44,45]. To investigate if secreted astrocytic
components could influence the gene expression of the
hCMEC/D3 and hpBEC cells, the cells were co-cultured with
astrocytes and transcriptome data was collected. The phenotypic
status of the astrocytes was verified using FACS analysis (Figure
S2). Numerous genes were significantly affected, but the change in
expression levels was small indicating low responsiveness towards
astrocytic factors (Figure 3a & 3b). Only 8.5% (1830 genes) in
the hCMEC/D3 cells and 2.2% (482 genes) in the hpBECs of all
21460 expressed genes (i.e. mean hybridization signal above cutoff
$5) were differentially expressed (adjusted p-values,0.05) be-
tween the control and the co-culturing conditions (Figure 3a &
3b). Thus, the vast majority of gene expression was not altered in
an environment containing astrocytes (Figure 3a & 3b). Proteins
belonging to the TJ family were not affected by the presence of
astrocytes (Table S1 & S4). Since we chose non-contact co-
culture conditions in order to avoid contamination by astrocytic
mRNA, this set up might explain the small gene expression
changes and indicate the importance of cell-cell interaction
through the astrocyte end-feet structures for the TJ protein
expression. However, genes that were significantly decreased in
both BECs in the presence of astrocytes could be assigned to cell-
cell adhesion, cell extravasation, immune response, response to
other organisms and cell migration (Figure 3c & Table S4). In
particular, the two genes most reduced by astrocytic co-culturing
in both cells were E-selectin and VCAM-1 (Figure 3a & 3b).
These two cell adhesion molecules are involved in leukocyte
recruitment and migration across the BBB [46,47]. FACS staining
for ICAM-1 on hCMEC/D3 cells confirmed the astrocytic effect
on ECs adhesion molecule expression (Figure S3). As a potent
source of immunologically relevant cytokines and chemokines
[48,49] it is conceivable that astrocytes may modulate the
expression of adhesion molecules that play a key role in
maintaining the immunologically privileged status of the brain.
Genes that were specifically affected by astrocytic co-culturing in
Key In Vitro Properties in In Vitro BBB Models
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e38149Figure 2. Induction of INF-stimulated genes in immortalized BECs. (A) Expression levels of total IFN, IFNa/b and IFNc signaling pathway
genes were determined by microarray analysis for the two BEC lines. Each circle represents one gene of the indicated reactome pathway and the
difference in expression between hCMEC/D3 and hpBEC cells. To compare IFN signaling reactomes between BEC lines, the values of the four
replicates were averaged, and the probe-set with the highest value was used to represent each gene. The distributions of the genes within each gene
set were compared with a one-sample t-test, to test whether the mean of the distributions were different from zero. (B) HLA class I, b2-microtublin
and b actin gene expression in resting hCMEC/D3 (red bars) and hpBECs (blue bars) determined by microarray analysis. All displayed HLA class I and
b2-microtublin genes were significantly (p,0.001) higher expressed in the hCMEC/D3 cells. (C–E) Flow cytometry analysis of surface expression of (C
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affected by astrocytic co-culturing only in one of the two cell lines
are displayed in Table S4. A gene set enrichment analysis for
hCMEC/D3 cells was performed. Only gene sets passing
conservative significance thresholds (p#0.05) are displayed in the
enrichment map (Figure 3d) resulting in 141 GO categories
which differed between controls and HA non-contact co-culturing
condition (Table S6). Almost all significant gene sets were lower
expressed in the HA co-culture condition and can be mostly
related to immune system regulation (Figure 3d & Table S6).
Expression of proteins important for tight junction
formation
One of the most distinct characteristics of BECs is the presence
of highly organized TJs. These TJs are responsible for the selective
permeability towards large and small molecules and the high
TEER value. Transmembrane proteins of TJ include occludin,
claudins and junctional adhesion molecules (JAM). These proteins
interact with cytosolic proteins such as occludens proteins (ZO)
which are associated with the actin network of the cell cytoskeleton
[50]. By specifically examining the expression of these proteins, it
could be shown that claudin-5, b-catenin and ZO-1 are present at
a certain level in the hCMEC/D3 cells and are expressed
&D ) HLA class I and (E) II molecules on hCMEC/D3 cells (red histograms, red bars) and hpBECs (blue histograms, blue bars). (C) The HLA class I
expression levels and the mean fluorescence intensities (MFI) on both resting BEC lines, in one of four similar experiments, is presented. (D) The effect
of IFNa upon HLA class I surface expression and (E) the effect of IFNc upon HLA class II surface expression on the two BEC lines are displayed as
average MFIs of three similar experiments. *p,0.05, **p,0.01 and ***p,0.001 (Student’s t-test).
doi:10.1371/journal.pone.0038149.g002
Figure 3. Astrocytic co-culturing reduced the expression of adhesion molecules. The expression of genes in (A) hCMEC/D3 and (B) hpBECs
was compared in presence and absence of human astrocytes (HA). The data is represented as a dot plot on a log2 scale, where each point represents
a probe set on the gene chip. Red and blue dots indicate probe sets, which are differently expressed (adjusted p#0.05) between culturing conditions.
Blue dots represent lower and red dots higher expressed probes in the co-culturing conditions with HAs versus culturing the BECs alone. The mean
expression values are averaged expression values for both cell lines. (C) Overlapping genes identified between the two BECs in the co-culturing
conditions with HAs. The numbers of up-regulated (red numbers) or down-regulated (blue numbers) genes in the BECs with HA co-culture are
displayed. (D) The enrichment map displays the differently expressed gene sets for hCMEC/D3 cells between culturing conditions. Blue node color
represents lower expression in hCMEC/D3 + HA, whereas red represents higher expression in hCMEC/D3 control. Node size is proportional to the
number of genes in the gene set and edge thickness represents the degree of overlap between two gene sets. Labels for the clusters of functionally
related gene sets were manually assigned: 1) Regulation of Immune Cell Activation and Proliferation, 2) Regulation of Kinase Cascade, 3) Regulation
of Inflammatory and Defense Response, 4) Response to Pathogens, 5) Regulation of the Immune System, 6) Response to Cytokines, 7) Regulation of
Cell-Cell Adhesion, 8) Cell Migration, 9) Signal Transduction, 10) Antigen Processing and Presentation, 11) Miscellaneous.
doi:10.1371/journal.pone.0038149.g003
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completely different picture emerged when the transcriptional
profiles were analyzed and compared to the mouse data obtained
from freshly isolated BECs [16]. The data clearly show that three
TJ specific genes, claudin-5, occludin and JAM2, are drastically
reduced in expression level in both cell lines compared to the
mouse cells (Figure 4). Claudin-5 has been shown to play an
important role in preventing small (,800 D) but not large
molecules crossing the BBB [51]. Furthermore, it has been shown
that the ratio between claudin-5 and -12 seems to be important for
proper TJ formation. Claudin-5 was 751-fold more expressed
compared to claudin-12 in rats [52]. A similar ratio was also found
using primary mouse BECs, where the mRNA expression levels of
claudin-5 was 28-fold higher than claudin-12 [16]. Our analysis of
the human primary and the immortalized BECs shows a much
smaller difference between claudin-5 and claudin-12. In hCMEC/
D3 cells the expression levels for these two claudins were almost
equal (Figure 4). Other proteins which are also less expressed in
both cultured BEC lines compared to the freshly isolated mouse
BECs [16] are ZO-1, ZO-2, claudin-12, tricellulin, a- and b-
catenin (Figure 4). They have also been described to be
important for the BBB tightness [53]. Interestingly, claudin-3
and ZO-3 are expressed at low levels in both cultured cell lines as
well as in the fresh preparation of mouse BECs. This could point
to a less important role for these two proteins in maintaining the
BBB integrity. One of the proteins which is for example higher
expressed in the cultured cell lines compared to the fresh ex vivo
mouse BECs is CD31, which is not surprising since CD31 was the
selection marker used during the isolation, characterization and
immortalization process of the hCMEC/D3 cells [15].
The comparison between the human cell lines and the mouse
data was performed by normalizing the expression levels to the
described housekeeping gene ribosomal protein L4 (RPL4) which
has been shown to be one of the top internal control genes for
cross-species comparison [54]. The procedure was confirmed by
comparing the normalized expression values for two other known
housekeeping genes, actin and the ribosomal protein S13 showing
that these genes are expressed at very similar levels in the cultured
human BEC lines and the freshly prepared mouse BECs
(Figure 4). In addition, all proposed housekeeping genes were
also analyzed and show only minor variations between species
(Figure S4) demonstrating that any of the newly validated
housekeeping genes [54] could have been used for gene expression
normalization.
Brain endothelial cell surface receptors expression
Another class of proteins important for BBB function are the cell
surface receptors e.g the Low Density Lipoprotein (LDL) receptor
family. These receptors are able to bind and internalize a plethora
of ligands and therefore play an important role in diverse
physiological processes. Some of the members have been described
to play a unique role in the transcytosis of various ligands at the
BBB. The expression levels of the LDL receptor family members
are shown in Figure 5 together with two other key endocytic
receptors, transferrin receptor (TfR) and the insulin receptor (IR).
The expression profile for these receptors is significantly different
in the in vitro BEC systems compared to the expression levels of
freshly prepared BECs [16] (Figure 5). Four receptor genes that
are higher expressed in vivo are LRP8, IR, IGF1R and FcRn. One
receptor expressed at high levels in vivo as well as in the cultured
BECs is the TfR (Figure 5). This receptor has already been
shown to be expressed on the hCMEC/D3 cells by FACS [55].
LRP1 and RAGE have been described to be involved in amyloid-
b transport across the BBB [56]. LRP1 has also been described to
be a transporter for various proteins and peptides over the BBB
[57]. However, both receptors are expressed at low levels in both
the cultured human and the freshly prepared mouse BECs
(Figure 5).
Brain endothelial transporter expression
To further investigate the status of the both BEC lines we next
examined the expression profiles for the two important transport
families, the solute carrier (SLC) and the ATP-binding cassette
(ABC) transporters [58,59]. These two classes of BBB proteins are
responsible for the transfer or exclusion of nutrients and toxic
agents. Notably, the majority of the substrates for these
transporters are small molecules, including a variety of dipeptides.
An overview of the SLC family gene expression profile is displayed
in Figure 6 and again compared to the freshly prepared BECs
from mouse [16]. The data is displayed using the same
normalization procedure using the housekeeping gene RPL4.
The highly expressed transporters identified using the mouse
BECs such as Glut1 (slc2a1), MCT1 (slc16a1), MCT8 (slc16a2),
TauT (slc6a6), CAT1 (slc7a1) and LAT1 (slc7a5) are expressed at
very low levels in both cultured human BECs. This is consistent
with the previous data on the TJs and receptors where BBB
specific genes are significantly reduced in expression levels in the
cultured human BECs. Thus, SLC family members that are
known to be involved in vital functions at the BBB and are
expressed at high levels at the BBB, show a more average
expression level in the cultured human BECs. We performed the
same analysis for the ABC transport family and strikingly the genes
which are highly expressed in the mouse BECs were strongly
reduced in the both cultured human BECs (Figure 7). The typical
ABC transporters at the BBB, such as Pgp, (ABCB1), MRP4
(ABCC4) and BCRP (ABCG2), were almost reduced to undetect-
able levels (Figure 7). Importantly, the change in expression levels
within these two families of transporters are affected in both
directions (ratio plot in Figure 6 and 7), indicating an
asymmetric perturbation of the transcriptional regulation machin-
ery. Cultured cells fail to maintain high levels of key BBB
transporters. Taken together, it appears that the unique expression
pattern of these typical BBB transporter family members
disappears when BECs are isolated from their natural environ-
ment.
Discussion
In this study we present evidence that those genes in BECs that
are highly expressed and described to be important for ensuring
BBB-like properties are particularly affected by culturing the cells
in isolation. This is most likely due to the loss of their native
environment within the neurovascular unit (NVU).
The information was gathered by investigating how BECs
respond to culture conditions without their in vivo surrounding.
Astrocytes, pericytes and neurons normally interact directly or
indirectly with the endothelium within the intricate structure of the
NVU [3,4,5,6]. For instance, it has been recently shown that
pericytes can have a direct effect on endothelial cell properties in
vivo, where reduced expression of pericytes increased the
transcellular transport across the endothelial cells [60,61].
Astrocytes have previously been described to modulate BBB
permeability [38] and recently it has been shown that astrocytes
have a pivotal role in dynamic signaling within the NVU related to
regulation of cerebral blood flow [62]. In this study we used two
independently derived human BECs, one of primary source
(hpBECs) and the other an immortalized cell line (hCMEC/D3).
We show that these two BECs have a very similar global gene
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2=0.91, p,1.68 ? 10
26). Importantly, both
cell types are pure endothelial cell populations based on the
presence of typical endothelial cell surface markers (Figure 1a–
1c).
Some of the major differences in gene expression can be
attributed to the immortalization procedure, where genes know to
be affected by SV40 large T antigen integration [30] have also
been altered in the hCMEC/D3 cell line. As a consequence of the
immortalization procedure genes belonging to RNA processing,
DNA repair, immune and virus response and mitosis are highly
and significantly up-regulated in the hCMEC/D3 cell line
(Figure 1f, Table S2 and S7). Genes that are expressed at
higher levels in the hpBEC based on the gene set enrichment
analysis belong to vesicle transport, endothelial migration and
catabolic/metabolic processes, possibly indicating a deficiency of
these properties in the hCMEC/D3 cell line. Genes related to the
IFN signaling pathway have higher expression levels in hCMEC/
D3 (Figure 2a). The expression of MHC class I and II genes are
significantly higher in the hCMEC/D3 cell line which is
confirmed by FACS analysis (Figure 2c–2e). The hpBECs are
more responsive towards IFN stimulation whereas the hCMEC/
D3 cells are already in an activated state (Figure 2d and 2e).
This indicates that immunological responses could be significantly
affected in the hCMEC/D3 cell line as a result of the
immortalization procedure. The hCMEC/D3 cells proliferate
faster (Figure 1d) and persist in a confluent state for a longer
period (Figure 1d). We speculate that the up regulated expression
of anaphase and mitosis related genes, identified by gene set
enrichment analysis (Figure 1f), alter the growth characteristics of
the hCMEC/D3 cells compared to the hpBECs. Thus, this
immortalized cell line should be used with caution, especially if
immunological processes are being investigated.
The coefficient determination (R
2) with and without astrocyte
co-culturing was 0.998 (p,4.18 ? 10
28) and 0.997 (p,5.88 ? 10
28)
for the hpBECs and the hCMEC/D3 cell line, respectively.
Overall, this demonstrates that none of the BECs responded
strongly to astrocytic co-culturing at the gene expression level
(Figure 3a and 3b). The data in the figures illustrate the low
number of genes that were affected by the presence of astrocytes.
This is in agreement with the unaltered functional properties of
these BECs, such as TEER values and paracellular permeability in
co-culture with astrocytes. Our transcriptional analysis of the
BECs in presence of astrocytes was performed in a non-contact
arrangement to avoid any risk of contamination by astrocytic
Figure 4. Differences in expression levels of TJ protein between cultured BECs and freshly isolated BECs. The RPL4 normalized mouse
expression values (Mouse) are compared to the also RPL4 normalized expression values of hpBECs (Average P) and hCMEC/D3 (Average D3). The
lower graph shows the absolute expression levels for each cell type. The upper graph shows the ratio between RPL4 normalized mouse BECs and
hpBECs (Ratio M/P); the ratio between RPL4 normalized mouse BECs and hCMEC/D3 (Ratio M/D3) and the ratio between hpBECs and hCMEC/D3
(Ratio P/D3). Three genes that are expressed in much lower levels in both the hpBECs and the hCMEC/D3 cell line are claudin-5, occludin and JAM2.
Two genes that are expressed at higher levels in the human cell lines are JAM3 and CD31.
doi:10.1371/journal.pone.0038149.g004
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the astrocytes might explain the low responsiveness of the BECs at
transcriptional level. However, when using a contact astrocyte co-
culturing set up, no significant change could be detected in either
TEER (BECs+HA=10–30 V/cm
2) or paracellular permeability
(Pe values: hCMEC/D3=3.560.2 ? 10
25 cm/sec, hCMEC/D3
+ HA 3.360.3 ? 10
25 cm/sec, hpBECs=3.460.4 ? 10
25 cm/sec,
hpBECs+HA=3.760.4 ? 10
25 cm/sec). There are reports
describing the effects of astrocytic co-culture in which the focus
of the study was on TJ properties. One recent study using an
immortalized mouse brain endothelial cell line in co-culture with
primary rat astrocytes showed a small but non-significant increase
in TEER but no changes in gene expression of various TJ proteins
[63]. Another recent investigation using primary porcine brain
endothelial cell showed that co-culturing with a mixture of
primary glial cell from rat could have a profound effect on the
endothelial cell properties, such as increased TEER values and
claudin-5 expression [42]. In addition, recently it was shown that
claudin-5 was significantly increased in three different in vitro BBB
models by the influence of astrocytes [64]. We were unable to
identify changes in gene expression related to TJs formation in
these two BECs using a non-contact astrocyte co-culturing set up.
However, we identify other genes that were significantly
influenced by the presence of astrocytes, and importantly some
of them were changed in both BECs (Figure 3c). Interestingly,
among these 140 genes that were significantly down-regulated in
both BECs in presence of astrocytes, many could be assigned to
genes involved in cell-cell adhesion, cellular extravasation and cell
migration GO categories. A closer statistical investigation of these
gene sets as whole indeed revealed a significant down-regulation of
their members in both BECs when co cultured with astrocytes. For
instance, E-selectin (SELE) together with vascular cell adhesion
molecule 1 (VCAM-1), intracellular cell adhesion molecule 1
(ICAM-1) and leucocyte surface antigen CD47 (MER6), all part of
the signaling platform for EC interaction with leukocytes [65], are
included in these common genes which were affected by astrocytic
co-culturing. Possibly, this could be related to the regulation of
leukocyte migration and extravasation into the CNS [65].
Leukocyte recruitment by ECs is regulated by the expression of
surface adhesion molecules, which are responsible for decelerating
and capturing circulating immune cells. The extent to which this
occurs is governed by the degree of expression and activity of these
surface adhesion molecules and the activation state of the
leukocytes. Based on these data we speculate that astrocytes might
Figure 5. Differences in expression levels of surface receptors between the cultured BECs and freshly isolated BECs. The RPL4
normalized mouse expression values (Mouse) (RPL4 normalized) are compared to the also RPL4 normalized expression values of hpBECs (Average P)
and hCMEC/D3 (Average D3). The lower graph shows the absolute expression levels for each cell type. The upper graph shows the ratio between
RPL4 normalized mouse BECs and hpBECs (Ratio M/P), the ratio between RPL4 normalized mouse BECs and hCMEC/D3 (Ratio M/D3) and the ratio
between hpBECs and hCMEC/D3 (Ratio P/D3). Four genes that are expressed in much lower levels in both the hpBECs and the hCMEC/D3 cell line are
Lrp8, IR, IGF1R and FcRn.
doi:10.1371/journal.pone.0038149.g005
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adhesion molecules, inducing a low expression and activation state
of adhesion molecules on BECs and thereby be directly involved in
the regulation of the immune surveillance status of the CNS. Thus,
astrocytes seem to have a specific function in cerebral vessels and
capillaries regulating extravasation of blood cells over the BBB,
this is not the case in the peripheral vasculature which lacks
astrocytic cells. These data are in agreement with a very recent
publication showing that sonic hedgehog which is produced by
astrocytes promotes immune quiescence of BBB ECs by decreas-
ing expression of proinflammatory mediators and the adhesion
and migration of leucocytes [66]
Certain key conclusions made in this paper are based on
comparison of the isolated human BECs transcriptome data with
the data generated using freshly purified BECs from mouse [16].
This is an important procedure since the mouse data can be
assumed to represent essential in vivo gene expression patterns
important for unique and distinctive BEC properties. We believe
this is a valid approach despite the species differences because the
established housekeeping gene RPL4 was used for normalization
of the probe signals [54]. In addition, by comparing the top 14
candidate housekeeping genes for human and mouse the average
ratio is 1.12 with a standard deviation of 0.518 (Figure S4). This
tight agreement between these housekeeping genes was obtained
even though these two data sets were obtained in two independent
studies. This is far below the expression differences we are using in
our discussions and conclusions regarding BBB specific genes.
Moreover, the human and mouse data comparison is also
consistent with an unbiased bidirectional change in expression
pattern within a family of genes with similar biological function,
such as for the SLC family depicted in Figure 8a. It is also
interesting to note that the correlation between the mouse and
human data is high, the coefficient of determination between
mouse and hpBECs and the hCMEC/D3 cell line is 0.482
(p,7.74 ? 10
25) and 0.455 (p,2.50 ? 10
29), respectively. This
means that about half of the variability in the human cells can be
explained by the variability in the mouse BECs. Potentially, the
half with global cross-species correlation could potentially repre-
sent transcripts which are not imposed by the natural in vivo
environment. While the other half of the gene set where no clear
correlation was obtained could belongs to transcripts that are
directly regulated within the NVU surroundings where most of
these genes belong to BBB specific transcripts discussed in this
paper. Recently, an extensive brain gene expression profiling
Figure 6. Differences in expression levels of SLC transporter between cultured BECs and freshly isolated BECs. The RPL4 normalized
mouse expression values (Mouse) are compared to the also RPL4 normalized expression values of hpBECs (Average P) and hCMEC/D3 (Average D3).
The lower graph shows the absolute expression levels for each cell type. The upper graph shows the ratio between RPL4 normalized mouse BECs and
hpBECs (Ratio M/P), the ratio between RPL4 normalized mouse BECs and hCMEC/D3 (Ratio M/D3) and the ratio between hpBECs and hCMEC/D3
(Ratio P/D3). For instance genes that are expressed in much lower levels in both hpBECs and the hCMEC/D3 cell line are GLUT1, MCT8 and OAT3.
doi:10.1371/journal.pone.0038149.g006
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analysis showed that gene expression is significantly preserved
between the two species (R=0.60; p,10
2400) [17].
A particular focus of this study was the understanding of TJ
properties at transcriptional level in order to elucidate some of the
key genetic attributes necessary for proper BBB function. Our
transcriptome data on the hCMEC/D3 cell line and the hpBECs
are in agreement with relative high paracellular leakiness and low
TEER values. In our hands, the hCMEC/D3 cells have a TEER
value in the region of 15–30 V/cm
2 which is in agreement with
published values [15] and is similar to values obtained in
peripheral capillaries. Similar low TEER values were also
obtained for the hpBECs. These numbers should be compared
to in vivo values where the resistance has been estimated to be
approximately 1500–8000 V/cm
2 [67,68,69]. Certain members of
the claudin [52] family and occludins [70] have been described to
regulate the diffusion of certain ions between ECs. Claudin
expression within the TJs seems to determine the ion selectivity of
the paracellular diffusion [52], meaning that not only the existence
of certain TJ proteins are important but also their expression levels
in relation to other TJ proteins. Our data shows that occludin and
claudin-5 are expressed at very low levels in the cultured human
BECs. These interpretations are based on mRNA quantification
and not on directly measured protein levels which could be
misleading. However, a recent investigation on thousands of genes
in mammalian cells shows a good correlation (R
2=0.41) between
mRNA and protein levels [71]. These two TJ proteins have been
described to play a pivotal role in maintaining low paracellular
permeability at the BBB [51,70,72,73]. Thus, the low expression of
claudin-5 and occludin are probably one of the reasons for the low
TEER values in these two cell lines. However, this might not be
corrected by a simple overexpression of only these two TJ proteins.
Correction of the levels of all TJ protein may be needed to
establish functionalities resembling in vivo properties. Our gene
expression analysis and the comparison with the mouse tran-
scriptome data indicate that the absolute levels and the relative
expression of some important TJ proteins in hCMEC/D3 cell line
and hpBECs are altered (Figure 4). The precise expression profile
of the TJ proteins in BECs is probably dictated by their
environment and this regulatory mechanism is altered when the
BECs are cultured in isolation. Recently, attempts have been
made to develop the properties of the hCMEC/D3 cell line by co-
culturing with astrocytes and pericytes [74] but so far the
improvement has been small. Thus this research area needs
additional attention to ensure further advancements.
Figure 7. Differences in expression levels of ABC transporter between cultured BECs and freshly isolated BECs. The RPL4 normalized
mouse expression values (Mouse) are compared to the also RPL4 normalized expression values of hpBECs (Average P) and hCMEC/D3 (Average D3).
The lower graph shows the absolute expression levels for each cell type. The upper graph shows the ratio between RPL4 normalized mouse BECs and
hpBECs (Ratio M/P), the ratio between RPL4 normalized mouse BECs and hCMEC/D3 (Ratio M/D3) and the ratio between hpBECs and hCMEC/D3
(Ratio P/D3). Three genes that are expressed in much lower levels in both the hpBECs and the hCMEC/D3 cell line are Pgp1, MRP4 and MDRA1.
doi:10.1371/journal.pone.0038149.g007
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BBB is thought to be facilitated by receptor-mediated transport
(RMT) [75]. The transferrin and insulin receptors have been
shown to transport cargo across the BBB using a transcytosis
mechanism [76]. These two receptors are expressed in both the
hCMEC/D3 cell line and the hpBECs based on our gene
expression data (Figure 5) and is in agreement with published
data [55]. However, other described transporters such as LRP1
and RAGE are expressed at very low levels in both the two
cultured human cell lines as well as in the freshly prepared mouse
BECs. The ability of these two receptors to transport amyloid-b
over the BBB is currently under investigations [77,78]. Interest-
Figure 8. Key BBB genes are expressed at low levels in cultured human BECs. (A) All genes for mouse BECs versus hCMEC/D3 are displayed
as grey dots. Tight junction genes (red square), SLC members (blue dot), ABC members (yellow triangle) and the surface receptors (green diamond)
are highlighted. The x-axis shows the ratio between mouse and hCMEC/D3 and the y-axis shows the ratio between mouse BECs and hCMEC/D3
multiplied by the expression levels in mouse BECs. Genes in the upper right corner are therefore highly expressed in mouse BECs and much more in
comparison to the hCMEC/D3 cell line. The graph shows that all key BBB genes are expressed at lower levels in the human cell line hCMEC/D3
(enlarged symbols). A similar result was obtained when comparing the mouse expression data to the hpBECs. (B) A schematic representation of the
key genes identified in this study to have low level of expression in the hCMEC/D3 cells. The picture illustrates the spatial location of the BBB genes
on BECs and the fold reduction in expression compared to mouse BECs.
doi:10.1371/journal.pone.0038149.g008
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levels in BECs based on the mouse in vivo data (Lrp8, IR, IGF1R
and FcRn) which fail to be maintained at high levels in the two
cultured human cell lines (Figure 5). Possibly, as seen for the TJ
proteins, the transcription of these receptors is specifically
regulated by the neighboring cells within the NVU.
Cell surface transporters are the gatekeepers for all cells and
organelles, controlling uptake and efflux of crucial compounds
such as sugars, amino acids, nucleotides, inorganic ions and drugs.
These transporters are especially important for BBB function since
they regulate homeostasis inside the brain by selectively deter-
mining what should be permitted to enter or exit the brain. The
two most important transport families are the SLC and ABC
transporters [79]. Strikingly, typical BBB transporters that are
highly expressed in the freshly prepared mouse BECs are in
general expressed at low levels in the two human cell lines
(Figure 6 and 7) This is clearly seen within the SLC family where
there is low expression of Glut1 (SLC2A1), MCT1 (SLC16A1),
MCT8 (SLC6A2), TauT (SLC6A6), CAT1 (SLC7A1) and LAT1
(SLC7A5). In the ABC family, members like Pgp (ABCB1), MRP4
(ABCC4) and BRCP (ABCG2) are also affected in a similar
manner. Thus, our data strongly suggest that transporters that are
highly expressed in vivo fail to be preserved in ECs in vitro.
Some of the key findings in this paper are summarized in
Figure 8 where the expression levels of all genes are compared
between the purified mouse BECs with the human immortalized
cell line hCMEC/D3. The distribution of the ratio in expression
levels among genes between the two BECs is centered at one,
demonstrating that equal amounts of genes are either up or down
regulated in the hCMEC/D3 cell line compared to the mouse
BECs. This is also the case when analyzing expression levels of
particular families of genes, indicating that the changes identified
are not due to a systematic loss of expression of entire family of
genes. For instance the expression of the large SLC family is evenly
distributed amongst all genes, which is also the case for the claudin
family members (Figure 8). However, genes that have been
described to possess a unique BBB function are all expressed at
very low levels in the hCMEC/D3 cell line (genes indicated in
Figure 8). The low expression levels of these characteristic BBB
genes were also seen for the hpBEC, suggesting that this massive
reduction in expression of typical BBB genes could be a general
phenomenon when BECs are studied in isolated cultures. The
mere presence of a particular protein detected by immunocyto-
chemistry is no guarantee for correct cellular function. The
absolute level of expression is very likely to influence the cellular
phenotypic properties.
In general, the findings of our study illuminate the need for
improved in vitro BBB models. Especially when complex biological
mechanisms such as transcellular transport, intracellular sorting of
proteins and extravasation of cells are being investigated. Detailed
characterization is necessary for better understanding of the data
generated in the in vitro models and its relevance. Importantly,
BECs are heavily influenced by their native environment and this
has to been taken into account when designing the right conditions
for a predictive in vitro BBB model.
Materials and Methods
Cell lines and culture conditions
Immortalized human capillary endothelial cells (hCMEC/D3)
were obtained under license from INSREM France (Weksler BB,
et al. (2005) Blood-brain barrier-specific properties of a human
adult brain endothelial cell line. Faseb J 19: 1872–1874) and the
human primary cerebral microvascular endothelial cells (hpBECs)
were purchased from the Applied Cell Biology Research Institute
(Kirkland, WA). The human primary astrocytes (HAs) were
purchased from ScienCell Research Laboratories (San Diego,
CA). The hCMEC/D3 cells used for the experiments were
between passage (p) 27 and 32. The hpBECs (p2) and the HAs (p3)
were grown for maximal 2 additional passages. All culture ware
(BD Falcon) and transwell filters (Millipore) (pore size 0.4 mm, high
density pores) were coated with rat tail collagen type I solution (BD
Bioscience) at a concentration of 10 ug/cm
2 for 1 hour at 37uC
according to the manufactures instructions. All endothelial cells
were grown in EBM-2 Medium (Lonza Bioscience) supplemented
with EGM-2 containing hFGF-B, VEGF, R3-IGF, ascorbic acid,
hEGF, hydrocortisone and heparin (Lonza Bioscience). For
functional assays the cells were grown in a growth factor depleted
EBM-2 medium containing 3% human serum (Blood Bank, Basel,
Switzerland) and 0.55 mM hydrocortisone (Sigma) in the following
referred as the resting medium. Cells were cultured in the
incubator at 37uC with 5% CO2, 95% fresh air and saturated
humidity. Cell culture medium was changed every 3 days.
Co-cultivation with human astrocytes
5610
4 HAs/cm
2 were seeded in astrocytic medium (ScienCell
Research Laboratories), containing astrocytic growth supplements
(ScienCell Research Laboratories) onto poly-L-lysine (Sigma)
coated 12 well plates. 3 days after seeding, after the HAs were
confluent, freshly collagen coated transwell filters were transferred
to the 12 well plates and the culture medium was replaced by
resting medium. 5610
4 of either hCMEC/D3 or hpBECs were
subsequently seeded onto the transwell filters and co-cultured for 3
days.
Interferon stimulation
Confluent hpBECs and hCMEC/D3 were treated with either
human recombinant IFNc (R&D Systems) or human recombinant
IFNa (Roferon-A, Roche, Switzerland) (100 U/ml each) for
16 hours at 37uC before they were Flow Cytometry analysed.
Real time impedance measurement
Cell growth behavior was continuously monitored every
15 minutes for 7 days using a Real Time Cell Analyzer
(xCeLLigence, Roche). For time-dependent cell response profiling,
100 ml of cell culture medium was added to the collagen I coated
96 well E-plates to obtain background reading followed by the
addition of 100 ul of cell suspension. The E-plates containing the
cells were allowed to incubate at RT for 15 minutes and placed on
the reader in the incubator for continuous recording of impedance
as reflected by cell index (CI). The CI curves are displayed as the
average of 4 replicates +/2 standard deviation. All the data was
normalized to the first impedance background measurement.
RNA extractions
For microarray analyses endothelial RNA was isolated from
four individual transwell filters per experimental setting: hCMEC/
D3, hCMEC/D3 + HA, hpBECs and hpBECs + HA. RNA
extractions were performed using RNeasy Mini Kit (Qiagen)
according to the manufacturer’s instructions. Quality and quantity
of all isolated RNAs were determined with a NanoDrop ND 1000
(NanoDrop Technologies) and a Bioanalyzer 2100 (Agilent). The
RNA integrity numbers in all cases were from 8.3 to 10 indicating
minimal RNA degradation.
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Whole genome expression profiles were generated for all
samples plus two control universal human reference RNA
(Stratagene) samples. Four Affymetrix chips were used for
microarray hybridization of each condition (i.e., cell-type, co
culturing). 100 ng of total RNA from each sample were used to
generate biotinylated aRNA, using the Affymetrix GeneChip 39
IVT Express kit according to manufacturer’s instructions (Affyme-
trix Inc, CA, USA). 16 hours incubation was used for the in vitro
transcription reaction. The cRNA samples were hybridized
overnight to Affymetrix U133 Plus 2.0 full genome oligonucleotide
arrays and then stained with Streptavidin-Phycoerythrin according
to the manufacturer’s instructions (Affymetrix). Arrays were
scanned using a GeneChip Scanner 3000 (Affymetrix) and signal
intensities were calculated automatically by Affymetrix GeneChip
Command Console. Microarray data were analyzed with R
(Version 2.11.1) using the affy, affyPLM, genefilter, and limma
Bioconductor packages. All arrays passed a QC inspection and
showed similar background values and distributions of signal
intensities. Preprocessing (probe summarization, background
correction and quantile normalization) was done with the RMA
algorithm. Before examining differential expression, spike-in probe
sets were removed, along with poor quality probe sets. These were
defined as probe sets with three or more probes that were poor
(e.g. the probe sequence was not unique, based on more recent
public annotations as well as internal annotations). Finally, probe
sets with low expression (14 or more samples with log2 expression
,5) across samples were removed [80] [81], leaving 21460 probe
sets in the final analysis. Differential expression was assessed using
the limma package, and multiple testing was taken into account by
using the false discovery rate (FDR) rather than unadjusted p-
values. Gene set enrichment analysis (GSEA; [82]) was used to
look for enrichment of differentially expressed genes between the
two cell types, based on Gene Ontology (GO) biological process
terms. Gene sets smaller than 10 or greater than 400 were not
included. If a gene had multiple probe sets targeting it, the probe
set with the highest mean expression (across all samples) was used.
For the human (in vitro) versus mouse (in vivo) comparison, log2
expression values were normalized to RPL4, a ribosomal protein
that has been shown to have relatively stable expression across
species [54]. The difference between the mouse and human values
were used as input for the GSEA algorithm from the Broad
Institute [81].
Flow Cytometry Analysis
Confluent resting Brain Endothelial Cells (BECs) or HAs
monolayers were detached from the transwell filters with
Trypsin-EDTA (Gibco). Single cell suspension was subsequently
incubated in resting medium at 37uC for 1 hour prior to the
staining. All antibodies were directly labeled and purchased from
BD Pharmingen. After the staining the cells were washed twice
with stain buffer (BD Pharmingen) and analyzed using a Guava
easyCyte flow cytometer (Millipore). For surface staining, 1610
6
cells were pelleted and incubated for 45 minutes at 4uC with the
following antibodies: anti-CD31-PE (WM59), anti-CD34-APC
(581/CD34), anti-CD105-Alexa647 (266), anti-CD54-PE (HA58),
anti-HLA-ABC-FITC (G46-2.6), anti-HLA-DR,DP,DQ-FITC
(Tu39), IgG1-PE (MOPC-21), IgG1-FITC (MOPC-21), IgG1-
APC (MOPC-21), IgG1-Alexa647 (MOPC-21) and IgG2a-FITC
(G155-178). For intracellelular staining 1610
6 pelleted HAs were
fixed (BD Cytofix) for at 37uC for 10 minutes, permeabilized (BD
Phosflow Perm III) on ice for 30 minutes and incubated with the
following: anti-GFAP-Alexa647 (1B4) and IgG2b-Alexa647 (27–35).
Supporting Information
Figure S1 Phase contrast microscopic imaging on
hpBECs and hCMEC/D3 cells. Phase contrast microscopy
of confluent hpBECs and hCMEC/D3 cells, at 3 days post seeding
on collagen coated plastic dish (bar=50 mm). The pictures
illustrate the typical phenotype of an endothelial cell monolayer
in which the cells partially aligned their grow position to each
other.
(TIF)
Figure S2 Human astrocytes analysis with FACS using
GFAP expression as a marker. Flow cytometry analysis of
confluent human Astrocytes (HAs) 3 days post seeding, seeded on
poly-L-lysine coated plastic dish. The intracellular staining was
done with the indicated antibody (green histogram) or a relevant
isotype control (tinted histogram). GFAP expression level in one of
three similar experiments is presented. A minor fraction of the cells
showed a high expression level of the GFAP whereas the vast
majority of HAs express GFAP at intermediate levels.
(TIF)
Figure S3 Brain endothelial cells in astrocyte co-cultur-
ing alter ICAM-1 expression levels. Flow cytometry analysis
of confluent hCMEC/D3 cells co-cultured with human Astrocytes
for 3 days. The mean fluorescence intensity (MFI) of ICAM-1
surface expression with (green histogram) and without (black
histogram) astrocytic co-culturing are shown. The grey histogram
shows the background binding of the relevant isotype control
antibody on hCMEC/D3 cells without co-culturing. One of three
similar experiments is displayed.
(TIF)
Figure S4 Gene expression analysis of housekeeping
genes from human and mouse brain endothelial cells.
(A) The variation of proposed housekeeping genes between
human and mouse probe sets after normalization using the Rpl4
gene showing low deviation from a ratio of one. The average ratio
for all 14 housekeeping genes are 1.12 with a standard deviation of
0.518. (B) Comparison of gene expression between hCMEC/D3
cells and mouse pBECs. The data is represented as a dot plot on a
log2 scale, where each point represents a probe set on the gene
chip. Red and blue dots indicate probe sets, which have higher
expression in hCMEC/D3 (red) or higher expression in mouse
pBECs (blue). Grey dots show the expression respectively
difference of expression of all 14 housekeeping genes between
the species.
(TIF)
Table S1 All average expression data.
(XLS)
Table S2 hCMEC D3 vs. hpBECs gene sets.
(XLS)
Table S3 IFN signaling reactomes hCMEC D3 vs.
hpBECs.
(XLS)
Table S4 BECs + HA, gene sets.
(XLS)
Table S5 BECs + HA, genes in hCMEC D3 and hpBECs.
(XLS)
Table S6 hCMEC D3 + HA, gene sets.
(XLS)
Table S7 Mouse pBECs vs. hCMEC/D3, gene sets.
(XLS)
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